Literature DB >> 9606609

What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the carcinogenic potency database.

L S Gold1, T H Slone, B N Ames.   

Abstract

Many important issues in carcinogenesis can be addressed using our Carcinogenic Potency Database, which analyzes and standardizes the literature of chronic carcinogenicity tests in laboratory animals. This review is an update and overview of our analyses during the past 15 years, using the current database that includes results of 5152 experiments on 1298 chemicals. We address the following: 1. More than half the 1298 chemicals tested in long-term experiments have been evaluated as carcinogens. We describe this positivity rate for several subsets of the data (including naturally occurring and synthetic chemicals), and we hypothesize and important role in the interpretation of results for increased cell division due to administration of high doses. 2. Methodological issues in the interpretation of animal cancer tests: constraints on the estimation of carcinogenic potency and validity problems associated with using the limited data from bioassays to estimate human risk, reproducibility of results in carcinogenesis bioassays, comparison of lifetable and summary methods of analysis, and summarizing carcinogenic potency when multiple experiments on a chemical are positive. 3. Positivity is compared in bioassays for two closely related species, rats and mice, tested under similar experimental conditions. We assess what information such a comparison can provide about interspecies extrapolation. 4. Rodent carcinogens induce tumors in 35 different target organs. We describe the frequency of chemicals that induce tumors in rats or mice at each target site, and we compare target sites of mutagenic and nonmutagenic rodent carcinogens. 5. A broad perspective on evaluation of possible cancer hazards from rodent carcinogens is given, by ranking 74 human exposures (natural and synthetic) on the HERP indes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9606609     DOI: 10.3109/03602539808996318

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  7 in total

Review 1.  Causality in cancer epidemiology.

Authors:  Pagona Lagiou; Hans-Olov Adami; Dimitrios Trichopoulos
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  Comparison of in vitro and in vivo clastogenic potency based on benchmark dose analysis of flow cytometric micronucleus data.

Authors:  Jeffrey C Bemis; John W Wills; Steven M Bryce; Dorothea K Torous; Stephen D Dertinger; Wout Slob
Journal:  Mutagenesis       Date:  2015-06-06       Impact factor: 3.000

3.  Genotoxic hazard of radiopharmaceuticals in humans: chemical and radiation aspects coupled to microdosing.

Authors:  H Lundqvist; G Antoni; B Långström
Journal:  Eur J Clin Pharmacol       Date:  2007-04-25       Impact factor: 3.064

Review 4.  Beryllium metal II. a review of the available toxicity data.

Authors:  Christian Strupp
Journal:  Ann Occup Hyg       Date:  2010-12-31

5.  Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature in 1993 to 1994 and by the National Toxicology Program in 1995 to 1996.

Authors:  L S Gold; N B Manley; T H Slone; L Rohrbach
Journal:  Environ Health Perspect       Date:  1999-08       Impact factor: 9.031

6.  3S - Systematic, systemic, and systems biology and toxicology.

Authors:  Lena Smirnova; Nicole Kleinstreuer; Raffaella Corvi; Andre Levchenko; Suzanne C Fitzpatrick; Thomas Hartung
Journal:  ALTEX       Date:  2018       Impact factor: 6.043

Review 7.  Are animal models predictive for humans?

Authors:  Niall Shanks; Ray Greek; Jean Greek
Journal:  Philos Ethics Humanit Med       Date:  2009-01-15       Impact factor: 2.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.